Article PDF
References
Westerlund A . Central nervous system side effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharmacol 1985;28(Suppl):7H.
Munroe WP, Rindone JP, Kreshner RM . Systemic side effects associated with the ophthalmic administration of timolol. Drug Intell Clin Pharm 1985;19:85–9.
Zimmerman TJ, Baumann JD, Hetherington J . Side effects of timolol. Surv Ophthalmol 1983;28(Suppl):243–9.
Passo MS, Palmer EA, Van Buskirk EM . Plasma timolol in glaucoma patients. Ophthalmology 1984;91:1361–3.
Zimmerman TJ, Kooner KS, Kandarkis AS, Zeigler LP . Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984;102:551–3.
Brismer K, Mogensen L, Wetterberg L . Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987;221:155–8.
Mort JR . Nightmare cessation following alteration of ophthalmic administration of a cholinergic and a beta-blocking agent. Ann Pharmacother 1992;626:914–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Negi, A., Thoung, D. & Dabbous, F. Nightmares with topical beta-blocker. Eye 14, 813–814 (2000). https://doi.org/10.1038/eye.2000.225
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.225